Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-06 03:42Core Viewpoint - The company, Innocare Pharma, will hold an investor briefing on November 14, 2025, to discuss its Q3 2025 financial results and address investor inquiries [2][3][4]. Group 1: Meeting Details - The investor briefing is scheduled for November 14, 2025, from 11:00 AM to 12:00 PM [4]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible online [4]. - Investors can participate in the meeting through the internet and submit questions in advance via the Roadshow Center or the company's email [5][6]. Group 2: Participants - Key participants in the meeting will include Dr. Jisong Cui (Chairman and CEO), Ms. Hu Lan (Independent Non-Executive Director), and Mr. Fu Xin (CFO) [4]. - The company may adjust the list of attendees based on special circumstances [4]. Group 3: Investor Interaction - Investors can submit questions from November 7 to November 13, 2025, before 4:00 PM [5]. - The company will respond to commonly asked questions during the briefing [3][5]. Group 4: Contact Information - For inquiries, investors can contact the domestic securities affairs department via phone or email [6]. - The details of the meeting and its main content will be available on the Roadshow Center after the event [6].